|
|
See Category: Diseases of the eye and adnexa
See Header: Retinal neovascularization, unspecified
ICD-10 (CM) Code and Descriptor
|
H35.052 |
Retinal neovascularization, unspecified, left eye
|
H35052 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 53.02%
|
25.11%
|
11.15%
|
4.46%
|
2.58%
|
1.43%
|
0.75%
|
0.29%
|
0.38%
|
0.29%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H35.052*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
67028
|
INJECTION EYE DRUG |
1,898
|
1,898
|
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
1,811
|
1,811
|
|
C9257
|
BEVACIZUMAB INJECTION |
1,084
|
5,407
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,029
|
1,029
|
|
J0178
|
AFLIBERCEPT INJECTION |
649
|
1,322
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
268
|
268
|
|
92250
|
FUNDUS PHOTOGRAPHY W/I&R |
126
|
126
|
|
J2778
|
RANIBIZUMAB INJECTION |
97
|
491
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
86
|
86
|
|
92235
|
FLUORESCEIN ANGRPH MLTIFRAME |
66
|
66
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
59
|
59
|
|
92202
|
OPSCPY EXTND ON/MAC DRAW |
51
|
51
|
|
J9035
|
BEVACIZUMAB INJECTION |
44
|
59
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
41
|
55
|
|
J7999
|
COMPOUNDED DRUG, NOC |
40
|
127
|
|
76512
|
OPH US DX B-SCAN |
24
|
24
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
21
|
21
|
|
99212
|
OFFICE O/P EST SF 10 MIN |
18
|
18
|
|
92133
|
CPTRZD OPH DX IMG PST SGM ON |
17
|
17
|
|
92083
|
EXTENDED VISUAL FIELD XM |
15
|
15
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H35.052 related to the following DRG Codes:
124-125
|
